AdvaMed® Commends Full House Passage of MDUFA V Agreement
The Advanced Medical Technology Association® (AdvaMed®) welcomes House passage of the MDUFA V agreement.
Press Releases
Your source for the latest medtech news from AdvaMed® and our members.
Filter By:
In New Report, AdvaMed® Seeks Ways to Increase Diversity in Clinical Research and Addressing Health Equities
The Advanced Medical Technology Association® (AdvaMed®) released a report titled “Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities”, a new document intended to outline considerations and approaches…
AdvaMed®, Member Company Executives Meet with Semiconductor Industry, Department of Commerce Officials on Chips to Ensure Patient Care Comes First
Scott Whitaker, President and CEO of the Advanced Medical Technology Association® (AdvaMed®), the largest global trade organization representing the medical technology sector, joined a meeting with Deputy Secretary of Commerce…
AdvaMed® Joins Biden Administration Working Group to Address Medtech Supply Chain Concerns That Could Soon Affect Patient Care
The Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade organization representing medical technology manufacturers, announced its new role in the Biden Administration’s Joint Supply Chain Resilience Working Group.
Press Contact
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
AdvaMed® Commends Unanimous House Committee Vote on MDUFA V Agreement
Scott Whitaker, president and CEO of AdvaMed®, the world’s largest trade association representing medical technology companies, released the following statement on progress this week in both houses of Congress.
New for Upcoming The MedTech Conference: AdvaMed® Announces Investor Forum, Including Session with Chief Executives for Corporate Purpose
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association® (AdvaMed®) released this statement from President and CEO Scott Whitaker.
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder Treatment
BlueWind Medical, Ltd., AdvaMed® member and developer of the innovative RENOVA iStim™ implantable tibial neuromodulation (iTNM) device for treatment of Overactive Bladder, today announced the addition of Charles F. (“Chuck”)…
AdvaMed® Welcomes FDA User Fee Legislative Package
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association® (AdvaMed®) released this statement from President and CEO Scott Whitaker.
Listen to AdvaMed®'s Podcast
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed®, Medtech Leaders, Commerce Secretary Raimondo Discuss Impact of Semiconductor Chip Shortage on Patient Care
Scott Whitaker, President and CEO of AdvaMed®, led a meeting of medtech CEOs and leaders with Secretary of Commerce Gina Raimondo to discuss semiconductor chip supply chain issues impacting the…